Journal of Alzheimer's disease : JAD
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Understanding Racial Disparities in Dementia Prevalence Among Veterans..
100:1075-1082.
2024
-
Pimavanserin's Safety Profile: Insights from a Phase 3b Clinical Trial..
99:1217-1220.
2024
-
The RESIST Study: Examining Cognitive Change in Rheumatoid Arthritis Patients with Mild Cognitive Impairment Being Treated with a TNF-Inhibitor Compared to a Conventional Synthetic Disease-Modifying Anti-Rheumatic Drug..
99:161-175.
2024
-
Anti-CMV IgG Seropositivity is Associated with Plasma Biomarker Evidence of Amyloid-β Accumulation..
98:593-600.
2024
-
"Landscape of Phase 2 Trials in Alzheimer's Disease": Perspective on Adaptive Trials..
98:859-861.
2024
-
A Community-Based Study of Dementia in Mexican American and Non-Hispanic White Individuals..
97:649-658.
2024
-
Aqueous and Plasma Levels of Phosphorylated Tau 181 in Individuals with Normal Cognition..
100:239-245.
2024
-
Association of Plasma Amyloid-β and Dementia Among Black and White Older Adults..
99:787-797.
2024
-
Dysfunctional Bladder Morphology and Functional Impairments Are Identified in the Alzheimer's Disease APPNL-G-F/NL-G-F Murine Model..
97:395-408.
2024
-
Multimorbidity, Social Engagement, and Age-Related Cognitive Decline in Older Adults from the Rancho Bernardo Study of Healthy Aging..
97:1689-1702.
2024
-
Patterns of Aging Changes in Bodyweight May Predict Alzheimer's Disease..
97:163-170.
2024
-
Short-Term Practice Effects on Cognitive Tests Across the Late Life Cognitive Spectrum and How They Compare to Biomarkers of Alzheimer's Disease..
99:321-332.
2024
-
Alzheimer's Disease Is a Multi-Organ Disorder: It May Already Be Preventable..
91:1277-1281.
2023
-
Apathy as a Predictor of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Texas Alzheimer's Research and Care Consortium (TARCC) Cohort-Based Analysis..
92:129-139.
2023
-
Assessing Longitudinal Cognitive Change in Mild Cognitive Impairment Using Estimated Standardized Regression-Based Formulas..
95:509-521.
2023
-
Association of Alcohol Consumption with Cognition in Older Population: The A4 Study..
93:1381-1393.
2023
-
Association of Brain Volume and Retinal Thickness in the Early Stages of Alzheimer's Disease..
91:743-752.
2023
-
Change in the Quick Dementia Rating System Across Time in Older Adults with and without Cognitive Impairment..
93:449-457.
2023
-
Cognitive Aging with Dementia, Mild Cognitive Impairment, or No Impairment: A Comparison of Same- and Mixed-Sex Couples..
92:109-128.
2023
-
Cognitive and Neuropsychological Profiles in Alzheimer's Disease and Primary Age-Related Tauopathy and the Influence of Comorbid Neuropathologies..
92:1037-1049.
2023
-
Costs During the Last Five Years of Life for Patients with Clinical and Pathological Confirmed Diagnosis of Lewy Body Dementia and Alzheimer's Disease..
92:457-466.
2023
-
Criterion Validation of Tau PET Staging Schemes in Relation to Cognitive Outcomes..
96:197-214.
2023
-
Delayed and More Variable Unimanual and Bimanual Finger Tapping in Alzheimer's Disease: Associations with Biomarkers and Applications for Classification..
95:1233-1252.
2023
-
Evaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer's Disease..
92:95-107.
2023
-
Gut Microbiota and Cognitive Function Among Women Living with HIV..
95:1147-1161.
2023
-
Implication of Circulating Extracellular Vesicles-Bound Amyloid-β42 Oligomers in the Progression of Alzheimer's Disease..
96:813-825.
2023
-
Informing Disclosure: Efficacy of a Brief Educational Intervention on Research Participants' Knowledge about Alzheimer's Disease Biomarkers..
96:515-522.
2023
-
Involvement of Informal Caregivers in Preventing Falls in Older Adults with Cognitive Impairment: A Rapid Review..
92:741-750.
2023
-
Mediation of Reduced Hippocampal Volume by Cerebral Amyloid Angiopathy in Pathologically Confirmed Patients with Alzheimer's Disease..
93:495-507.
2023
-
Metabolic and Vascular Risk Factor Variability Over 25 Years Relates to Midlife Brain Volume and Cognition..
91:627-635.
2023
-
Microglial Imaging in Alzheimer's Disease and Its Relationship to Brain Amyloid: A Human 18F-GE180 PET Study..
96:1505-1514.
2023
-
Mild Cognitive Impairment is Associated with Poorer Everyday Decision Making..
94:1607-1615.
2023
-
Multidimensional Sleep Health and Long-Term Cognitive Decline in Community-Dwelling Older Men..
96:65-71.
2023
-
Neuropsychological Assessment of Older Adults in Nepal for Population-Based Dementia Ascertainment: Needs, Challenges, and Opportunities..
96:1339-1352.
2023
-
Novel Genetic Variants in TP37, PIK3R1, CALM1, and PLCG2 of the Neurotrophin Signaling Pathway Are Associated with the Progression from Mild Cognitive Impairment to Alzheimer's Disease..
91:977-987.
2023
-
Paving the Way for Alzheimer's Disease Prevention: A Systematic Review of Global Open-Access Neuroimaging Datasets in Healthy Individuals..
96:1441-1451.
2023
-
Predicting Progression to Clinical Alzheimer's Disease Dementia Using the Random Survival Forest..
95:535-548.
2023
-
Prodromal Motoric Cognitive Risk Syndrome and Everyday Function..
96:695-704.
2023
-
Progression from Prodromal Alzheimer's Disease to Mild Alzheimer's Disease Dementia in the Verubecestat APECS Study: Adjudicating Diagnostic Transitions..
92:341-348.
2023
-
Race Differences in the Association Between Sleep Medication Use and Risk of Dementia..
91:1133-1139.
2023
-
Race and Ethnicity in Lewy Body Dementia: A Narrative Review..
94:861-878.
2023
-
Racial/Ethnic Disparities in Misidentification of Dementia in Medicare Claims: Results from the Washington Heights-Inwood Columbia Aging Project..
96:359-368.
2023
-
Retention of Study Partners in Longitudinal Studies of Alzheimer Disease..
94:189-199.
2023
-
Sex Differences in the Associations of Obesity with Tau, Amyloid PET, and Cognitive Outcomes in Preclinical Alzheimer's Disease: Cross-Sectional A4 Study..
95:615-624.
2023
-
Sexually Dimorphic Association of Circulating Plasminogen Activator Inhibitor-1 Levels and Body Mass Index with Cerebrospinal Fluid Biomarkers of Alzheimer's Pathology in Preclinical Alzheimer's Disease..
91:1073-1083.
2023
-
TDP-43 Pathology in the Setting of Intermediate and High Alzheimer's Disease Neuropathologic Changes: A Preliminary Evaluation Across Ethnoracial Groups..
91:1291-1301.
2023
-
The Spectrum of Alzheimer-Type Pathology in Cognitively Normal Individuals..
91:683-695.
2023
-
Tryptophan Metabolism and Neurodegeneration: Longitudinal Associations of Kynurenine Pathway Metabolites with Cognitive Performance and Plasma Alzheimer's Disease and Related Dementias Biomarkers in the Duke Physical Performance Across the LifeSpan Study..
91:1141-1150.
2023
-
Vaccination Against Pneumonia May Provide Genotype-Specific Protection Against Alzheimer's Disease..
96:499-505.
2023
-
Validation of a Multivariate Prediction Model of the Clinical Progression of Alzheimer's Disease in a Community-Dwelling Multiethnic Cohort..
95:93-117.
2023
-
"Captive by the Uncertainty"-Experiences with Anticipatory Guidance for People Living with Dementia and Their Caregivers at a Specialty Dementia Clinic..
86:787-800.
2022
-
"I Didn't Sign Up for This": Perspectives from Persons Living with Dementia and Care Partners on Challenges, Supports, and Opportunities to Add Geriatric Neuropalliative Care to Dementia Specialty Care..
90:1301-1320.
2022
-
A Mixed-Methods Study of the Impact of Mild Cognitive Impairment Diagnosis on Patient and Care Partner Perception of Health Risks..
85:1175-1187.
2022
-
Anticholinergic Drug Burden and Neurocognitive Performance in the Study of Latinos-Investigation of Neurocognitive Aging..
86:53-65.
2022
-
Association of Antihypertensives and Cognitive Impairment in Long-Term Care Residents..
86:1149-1158.
2022
-
Association of Carotid Intima Media Thickening with Future Brain Region Specific Amyloid-β Burden..
89:223-232.
2022
-
Associations Between Brainstem Volume and Alzheimer's Disease Pathology in Middle-Aged Individuals of the Framingham Heart Study..
86:1603-1609.
2022
-
Associations Between Midlife Functional Limitations and Self-Reported Health and Cognitive Status: Results from the 1998-2016 Health and Retirement Study..
85:1621-1637.
2022
-
Blood Phosphorylated Tau 181 as a Biomarker for Amyloid Burden on Brain PET in Cognitively Healthy Adults..
87:1517-1526.
2022
-
Blood Pressure and Later-Life Cognition in Hispanic and White Adults (BP-COG): A Pooled Cohort Analysis of ARIC, CARDIA, CHS, FOS, MESA, and NOMAS..
89:1103-1117.
2022
-
Cancer and Vascular Comorbidity Effects on Dementia Risk and Neuropathology in the Oldest-Old..
90:405-417.
2022
-
Characterization of Mild Cognitive Impairment and Dementia among Community-Dwelling Mexican Americans and Non-Hispanic Whites..
90:905-915.
2022
-
Cognitive Function Associated with Gut Microbial Abundance in Sucrose and S-Adenosyl-L-Methionine (SAMe) Metabolic Pathways..
87:1115-1130.
2022
-
Comparative Analysis of Alzheimer's Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-Based Approach..
89:193-207.
2022
-
Concordance Between Self-Reported Medical Diagnosis of Mild Cognitive Impairment/Dementia and Neurocognitive Function Among Middle-Aged and Older Hispanic/Latino Adults: Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) and the Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA)..
88:45-55.
2022
-
Detecting Alzheimer's Disease Using Natural Language Processing of Referential Communication Task Transcripts..
86:1385-1398.
2022
-
Diet Patterns, the Gut Microbiome, and Alzheimer's Disease..
88:933-941.
2022
-
Difficulties with Activities of Daily Living and Receipt of Care Among Older Adults with Cognitive Impairment: Differences Between Those Living Alone and Those Living with Others..
89:31-37.
2022
-
Dysphagia Profiles Among Inpatients with Dementia Referred for Swallow Evaluation..
89:351-358.
2022
-
Importance of Accounting for Regional Differences in Modifiable Risk Factors for Alzheimer's Disease and Related Dementias: The Case for Tailored Interventions..
89:563-570.
2022
-
Increased Financial Altruism is Associated with Alzheimer's Disease Neurocognitive Profile in Older Adults..
88:995-1005.
2022
-
Lack of Any Caregiving for Those with Dementia..
86:531-535.
2022
-
Lessons from Detecting Cognitive Impairment Including Dementia (DetectCID) in Primary Care..
86:655-665.
2022
-
Machine Learning Based Multimodal Neuroimaging Genomics Dementia Score for Predicting Future Conversion to Alzheimer's Disease..
87:1345-1365.
2022
-
Measuring Subjective Cognitive Decline in Older Adults: Harmonization Between the Cognitive Change Index and the Measurement of Everyday Cognition Instruments..
87:761-769.
2022
-
Neuropathological and Clinical Correlates of Lewy Body Disease Survival by Race and Ethnicity in the National Alzheimer's Coordinating Center..
89:1339-1349.
2022
-
Neuropsychiatric Inventory-Questionnaire Assessed Nighttime Behaviors in Cognitively Asymptomatic Patients with Pathologically Confirmed Alzheimer's Disease Predict More Rapid Cognitive Deterioration..
86:1137-1147.
2022
-
Neuropsychological, Metabolic, and Connectivity Underpinnings of Semantic Interference Deficits Using the LASSI-L..
90:823-840.
2022
-
Non-Alcoholic Fatty Liver Disease, Liver Fibrosis, and Regional Amyloid-β and Tau Pathology in Middle-Aged Adults: The Framingham Study..
86:1371-1383.
2022
-
Olfactory Function and Markers of Brain Pathology in Non-Demented Individuals with Autosomal Dominant Alzheimer's Disease..
88:721-729.
2022
-
Polygenic Scores of Alzheimer's Disease Risk Genes Add Only Modestly to APOE in Explaining Variation in Amyloid PET Burden..
88:1615-1625.
2022
-
Predictors of Life Expectancy in Autopsy-Confirmed Alzheimer's Disease..
86:271-281.
2022
-
Predictors of Mortality in Individuals with Dementia in the National Alzheimer's Coordinating Center..
86:1935-1946.
2022
-
Proteomic Profiles of Neurodegeneration Among Mexican Americans and Non-Hispanic Whites in the HABS-HD Study..
86:1243-1254.
2022
-
Quantitative Gradient Echo MRI Identifies Dark Matter as a New Imaging Biomarker of Neurodegeneration that Precedes Tisssue Atrophy in Early Alzheimer's Disease..
85:905-924.
2022
-
Serum Levels of α-Klotho Are Correlated with Cerebrospinal Fluid Levels and Predict Measures of Cognitive Function..
86:1471-1481.
2022
-
Sex Differences in Alzheimer's Disease Revealed by Free-Water Diffusion Tensor Imaging and Voxel-Based Morphometry..
85:395-414.
2022
-
Sex Differences in Resilience and Resistance to Brain Pathology and Dysfunction Moderated by Cerebrovascular Response to Exercise and Genetic Risk for Alzheimer's Disease..
90:535-542.
2022
-
Sex Modifies the Associations of APOEɛ4 with Neuropsychiatric Symptom Burden in Both At-Risk and Clinical Cohorts of Alzheimer's Disease..
90:1571-1588.
2022
-
Sex-Specific Patterns of Body Mass Index Relationship with White Matter Connectivity..
86:1831-1848.
2022
-
Spoken Word Recognition in Listeners with Mild Dementia Symptoms..
90:749-759.
2022
-
The Advisory Group on Risk Evidence Education for Dementia: Multidisciplinary and Open to All..
90:953-962.
2022
-
The Brain Health Platform: Combining Resilience, Vulnerability, and Performance to Assess Brain Health and Risk of Alzheimer's Disease and Related Disorders..
90:1817-1830.
2022
-
Use of Cognitive Testing, Questionnaires, and Plasma Biomarkers to Quantify Cognitive Impairment in an Aging Pet Dog Population..
87:1367-1378.
2022
-
What Influences the Willingness of Blacks and African Americans to Enroll in Preclinical Alzheimer's Disease Biomarker Research? A Qualitative Vignette Analysis..
87:1167-1179.
2022
-
Rheumatoid Arthritis, Cognitive Impairment, and Neuroimaging Biomarkers: Results from the Mayo Clinic Study of Aging.
89:943-954.
2022
-
A Brief Digital Cognitive Assessment for Detection of Cognitive Impairment in Cuban Older Adults..
79:85-94.
2021
-
A Modified CAIDE Risk Score as a Screening Tool for Cognitive Impairment in Older Adults..
82:1755-1768.
2021
-
APOE4 Copy Number-Dependent Proteomic Changes in the Cerebrospinal Fluid..
79:511-530.
2021
-
Alzheimer's Disease-Related Neuropathology Among Patients with Medication Treated Type 2 Diabetes in a Community-Based Autopsy Cohort..
83:1303-1312.
2021
-
Antemortem Visit-To-Visit Blood Pressure Variability Predicts Cerebrovascular Lesion Burden in Autopsy-Confirmed Alzheimer's Disease..
83:65-75.
2021
-
Association Between Early Psychotic Symptoms and Alzheimer's Disease Prognosis in a Community-Based Cohort..
81:1131-1139.
2021
-
Association Between Polygenic Risk Score and the Progression from Mild Cognitive Impairment to Alzheimer's Disease..
84:1323-1335.
2021
-
Central Obesity, Cardiometabolic Risk, and Cognitive Change in the Study of Latinos - Investigation of Neurocognitive Aging..
82:1203-1218.
2021
-
Cerebrospinal Fluid Proteome Changes in Older Non-Cardiac Surgical Patients with Postoperative Cognitive Dysfunction..
80:1281-1297.
2021
-
Cigarette Smoking Status, Cigarette Exposure, and Duration of Abstinence Predicting Incident Dementia and Death: A Multistate Model Approach..
80:1013-1023.
2021
-
Classification, Prediction, and Concordance of Cognitive and Functional Progression in Patients with Mild Cognitive Impairment in the United States: A Latent Class Analysis..
82:1667-1682.
2021
-
Clinical and Paraclinical Measures Associated with Outcome in Cerebral Amyloid Angiopathy with Related Inflammation..
80:133-142.
2021
-
Cognition at Each Stage of Lewy Body Disease with Co-occurring Alzheimer's Disease Pathology..
80:1243-1256.
2021
-
Communicating 5-Year Risk of Alzheimer's Disease Dementia: Development and Evaluation of Materials that Incorporate Multiple Genetic and Biomarker Research Results..
79:559-572.
2021
-
Dementia Caregivers' Experiences Engaging Supportive Services While Residing in Under-Resourced Areas..
84:169-177.
2021
-
Depressive Symptoms Imputed Across the Life Course Are Associated with Cognitive Impairment and Cognitive Decline..
83:1379-1389.
2021
-
Documentation of Dementia as a Cause of Death Among Mexican-American Decedents Diagnosed with Dementia..
82:1727-1736.
2021
-
Effect of Age on Clinical Trial Outcome in Participants with Probable Alzheimer's Disease..
82:1243-1257.
2021
-
Four Common Late-Life Cognitive Trajectories Patterns Associate with Replicable Underlying Neuropathologies..
82:647-659.
2021
-
Gene-Specific DNA Methylation Linked to Postoperative Cognitive Dysfunction in Apolipoprotein E3 and E4 Mice..
83:1251-1268.
2021
-
Global Perspectives on Brief Cognitive Assessments for Dementia Diagnosis..
82:1001-1013.
2021
-
Glucose-Dementia Association Is Consistent Over Blood Pressure/Antihypertensive Groups..
80:79-90.
2021
-
Hemochromatosis Mutations, Brain Iron Imaging, and Dementia in the UK Biobank Cohort..
79:1203-1211.
2021
-
Hispanic Perspectives on Parkinson's Disease Care and Research Participation..
81:809-819.
2021
-
How Well Does Subjective Cognitive Decline Correspond to Objectively Measured Cognitive Decline? Assessment of 10-12 Year Change..
83:291-304.
2021
-
Hypertension and Hypercholesterolemia Modify Dementia Risk in Relation to APOEɛ4 Status..
81:1493-1504.
2021
-
Identifying Preclinical Alzheimer's Disease Using Everyday Driving Behavior: Proof of Concept..
79:1009-1014.
2021
-
Levels of Receptor for Advanced Glycation End Products and Glyoxalase-1 in the Total Circulating Extracellular Vesicles from Mild Cognitive Impairment and Different Stages of Alzheimer's Disease Patients..
84:227-237.
2021
-
Long-Term Exposure to Ambient Air Pollution and Cognitive Function Among Hispanic/Latino Adults in San Diego, California..
79:1489-1496.
2021
-
Longitudinal Body Weight Change, Visit-To-Visit Body Weight Fluctuation, and Cognitive Decline Among Older Adults..
84:777-786.
2021
-
Multiple Neurodegenerative Pathologies in an Alzheimer's Disease Patient Treated with Fornical Deep Brain Stimulation..
80:1383-1387.
2021
-
Neuropsychological Predictors of Severe Functional Dependency in a Multiethnic Community Cohort of Individuals with Alzheimer's Disease..
83:539-544.
2021
-
Obesity and White Matter Neuroinflammation Related Edema in Alzheimer's Disease Dementia Biomarker Negative Cognitively Normal Individuals..
79:1801-1811.
2021
-
Olfactory Impairment Is Related to Tau Pathology and Neuroinflammation in Alzheimer's Disease..
80:1051-1065.
2021
-
PET Imaging of Tau Pathology and Amyloid-β, and MRI for Alzheimer's Disease Feature Fusion and Multimodal Classification..
84:1497-1514.
2021
-
Passively-Measured Routine Home Computer Activity and Application Use Can Detect Mild Cognitive Impairment and Correlate with Important Cognitive Functions in Older Adulthood..
81:1053-1064.
2021
-
Peripheral Markers of Vascular Endothelial Dysfunction Show Independent but Additive Relationships with Brain-Based Biomarkers in Association with Functional Impairment in Alzheimer's Disease..
80:1553-1565.
2021
-
Plasma Biomarkers of Alzheimer's Disease in African Americans..
79:323-334.
2021
-
Pre-Loss Grief in Caregivers of Older Adults with Dementia with Lewy Bodies..
82:1847-1859.
2021
-
Pre-Statistical Considerations for Harmonization of Cognitive Instruments: Harmonization of ARIC, CARDIA, CHS, FHS, MESA, and NOMAS..
83:1803-1813.
2021
-
Psychosocial Factors Associated with Cognitive Function Among Middle-Aged and Older Hispanics/Latinos: The Hispanic Community Health Study/Study of Latinos and its Sociocultural Ancillary Study..
79:433-449.
2021
-
Screening for Early-Stage Alzheimer's Disease Using Optimized Feature Sets and Machine Learning..
81:355-366.
2021
-
Segmented Linear Mixed Model Analysis Reveals Association of the APOEɛ4 Allele with Faster Rate of Alzheimer's Disease Dementia Progression..
82:921-937.
2021
-
Self-Reported Dementia-Related Diagnosis Underestimates the Prevalence of Older Americans Living with Possible Dementia..
82:373-380.
2021
-
Stages of Objective Memory Impairment Predict Alzheimer's Disease Neuropathology: Comparison with the Clinical Dementia Rating Scale-Sum of Boxes..
80:185-195.
2021
-
The Effect of Baseline Patient and Caregiver Mindfulness on Dementia Outcomes..
79:1345-1367.
2021
-
The Free and Cued Selective Reminding Test Predicts Braak Stage..
80:175-183.
2021
-
The Utility of Assessing Health-Related Quality of Life to Predict Cognitive Decline and Dementia..
80:895-904.
2021
-
UDSNB 3.0 Neuropsychological Test Norms in Older Adults from a Diverse Community: Results from the Einstein Aging Study (EAS)..
83:1665-1678.
2021
-
Neuroticism Is Associated with Tau Pathology in Cognitively Unimpaired Individuals with Autosomal Dominant Alzheimer's Disease..
82:1809-1822.
2021
-
Assessing the Reliability of Reported Medical History in Older Adults..
78:643-652.
2020
-
Association of Cardiovascular Risk Factors with Cerebral Perfusion in Whites and African Americans..
75:649-660.
2020
-
Association of Hypercholesterolemia with Alzheimer's Disease Pathology and Cerebral Amyloid Angiopathy..
73:1305-1311.
2020
-
CCL23: A Chemokine Associated with Progression from Mild Cognitive Impairment to Alzheimer's Disease..
73:1585-1595.
2020
-
Cardiovascular Risk and Cognitive Function in Middle-Aged and Older Hispanics/Latinos: Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)..
73:103-116.
2020
-
Co-Prevalence of Alzheimer's Disease and Age-Related Macular Degeneration Established by Histopathologic Diagnosis..
76:207-215.
2020
-
Cognition and Daily Functioning: Results from the Hispanic Community Health Study/Study of Latinos (SOL) and Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA)..
77:1267-1278.
2020
-
Dementia in People with a Turkish Migration Background: Experiences and Utilization of Healthcare Services..
77:865-875.
2020
-
Depression is Associated with Tau and Not Amyloid Positron Emission Tomography in Cognitively Normal Adults..
74:1045-1055.
2020
-
Ethical Issues Raised by the Introduction of Artificial Companions to Older Adults with Cognitive Impairment: A Call for Interdisciplinary Collaborations..
76:445-455.
2020
-
Ethnoracial Differences in Lewy Body Diseases with Cognitive Impairment..
77:165-174.
2020
-
Evidence for the Utility of Actuarial Neuropsychological Criteria Across the Continuum of Normal Aging, Mild Cognitive Impairment, and Dementia..
78:371-386.
2020
-
Examination of the Effect of Rare Variants in TREM2, ABI3, and PLCG2 in LOAD Through Multiple Phenotypes..
77:1469-1482.
2020
-
Examining Cognitive Decline Across Black and White Participants in the Harvard Aging Brain Study..
75:1437-1446.
2020
-
Factors Associated with Mortality Including Nursing Home Transitions: A Retrospective Analysis of 25,418 People Prescribed Anti-Dementia Drugs in Northern Ireland..
73:1233-1242.
2020
-
Falls Associate with Neurodegenerative Changes in ATN Framework of Alzheimer's Disease..
77:745-752.
2020
-
Future Directions for Dementia Risk Reduction and Prevention Research: An International Research Network on Dementia Prevention Consensus..
78:3-12.
2020
-
Increased Cerebrospinal Fluid Amyloid-β During Sleep Deprivation in Healthy Middle-Aged Adults Is Not Due to Stress or Circadian Disruption..
75:471-482.
2020
-
Late-Life Physical and Cognitive Activities Independently Contribute to Brain and Cognitive Resilience..
74:363-376.
2020
-
Lower Left Ventricular Ejection Fraction Relates to Cerebrospinal Fluid Biomarker Evidence of Neurodegeneration in Older Adults..
74:965-974.
2020
-
Methods and Early Recruitment of a Community-Based Study of Cognitive Impairment Among Mexican Americans and Non-Hispanic Whites: The BASIC-Cognitive Study..
73:185-196.
2020
-
Neurofilament Light Predicts Decline in Attention but Not Episodic Memory in Preclinical Alzheimer's Disease..
74:1119-1129.
2020
-
Neuropathological Correlates of Cumulative Benzodiazepine and Anticholinergic Drug Use..
74:999-1009.
2020
-
Older Patients with Alzheimer's Disease-Related Cortical Atrophy Who Develop Post-Operative Delirium May Be at Increased Risk of Long-Term Cognitive Decline After Surgery..
75:187-199.
2020
-
Oxidized Products of Omega-6 and Omega-3 Long Chain Fatty Acids Are Associated with Increased White Matter Hyperintensity and Poorer Executive Function Performance in a Cohort of Cognitively Normal Hypertensive Older Adults..
74:65-77.
2020
-
Pharmaceutical Treatment for Alzheimer's Disease and Related Dementias: Utilization and Disparities..
76:579-589.
2020
-
Plasma Glial Fibrillary Acidic Protein Levels Differ Along the Spectra of Amyloid Burden and Clinical Disease Stage..
78:265-276.
2020
-
Pre-Diabetes, but not Type 2 Diabetes, Is Related to Brain Amyloid in Late Middle-Age..
75:1241-1252.
2020
-
Resting State Functional Connectivity Signature Differentiates Cognitively Normal from Individuals Who Convert to Symptomatic Alzheimer's Disease..
74:1085-1095.
2020
-
Screening for Lifetime History of Traumatic Brain Injury Among Older American and Irish Adults at Risk for Dementia: Development and Validation of a Web-Based Survey..
74:699-711.
2020
-
Sex Differences in in vivo Alzheimer's Disease Neuropathology in Late Middle-Aged Hispanics..
74:1243-1252.
2020
-
Stressful Life Events and Racial Disparities in Cognition Among Middle-Aged and Older Adults..
73:671-682.
2020
-
The MARBLE Study Protocol: Modulating ApoE Signaling to Reduce Brain Inflammation, DeLirium, and PostopErative Cognitive Dysfunction..
75:1319-1328.
2020
-
The U-ARE Protocol: A Pragmatic Approach to Decisional Capacity Assessment for Clinical Research..
73:431-442.
2020
-
Waist Circumference and Domain-Specific Cognitive Function Among Non-Demented Japanese Older Adults Stratified by Sex: Results from the Takashima Cognition Study..
73:887-896.
2020
-
A δ Homolog for Dementia Case Finding with Replication in the Alzheimer's Disease Neuroimaging Initiative..
67:67-79.
2019
-
APOE ɛ4/ɛ4 Is Associated with Aberrant Motor Behavior Through Both Lewy Body and Cerebral Amyloid Angiopathy Pathology in High Alzheimer's Disease Pathological Load..
72:1077-1087.
2019
-
Adverse Vascular Risk Relates to Cerebrospinal Fluid Biomarker Evidence of Axonal Injury in the Presence of Alzheimer's Disease Pathology..
71:281-290.
2019
-
An UNC5C Allele Predicts Cognitive Decline and Hippocampal Atrophy in Clinically Normal Older Adults..
68:1161-1170.
2019
-
Association of Cardiovascular and Alzheimer's Disease Risk Factors with Intracranial Arterial Blood Flow in Whites and African Americans..
72:919-929.
2019
-
Associations between Comorbid TDP-43, Lewy Body Pathology, and Neuropsychiatric Symptoms in Alzheimer's Disease..
69:953-961.
2019
-
Circulating and Extracellular Vesicles Levels of N-(1-Carboxymethyl)-L-Lysine (CML) Differentiate Early to Moderate Alzheimer's Disease..
69:751-762.
2019
-
Complex Walking Tasks and Risk for Cognitive Decline in High Functioning Older Adults..
71:S65-S73.
2019
-
Dementia Risk Elevates Brain Activity During Memory Retrieval: A Functional MRI Analysis of Middle Aged and Older Adults..
70:1005-1023.
2019
-
Differences in Cataract Surgery Rates Based on Dementia Status..
69:423-432.
2019
-
Early-Stage Alzheimer's Disease Is Associated with Simultaneous Systemic and Central Nervous System Dysregulation of Insulin-Linked Metabolic Pathways..
68:657-668.
2019
-
Evaluation of Associations of Alzheimer's Disease Risk Variants that Are Highly Expressed in Microglia with Neuropathological Outcome Measures..
70:659-666.
2019
-
Frailty and Risk of Incident Motoric Cognitive Risk Syndrome..
71:S85-S93.
2019
-
Greater Regional Cortical Thickness is Associated with Selective Vulnerability to Atrophy in Alzheimer's Disease, Independent of Amyloid Load and APOE Genotype..
69:145-156.
2019
-
Heterogeneity of Informant-Reported Functional Performance in Mild Cognitive Impairment: A Latent Profile Analysis of the Functional Activities Questionnaire..
68:1611-1624.
2019
-
Long-Term Trazodone Use and Cognition: A Potential Therapeutic Role for Slow-Wave Sleep Enhancers..
67:911-921.
2019
-
Neuropsychological Decline Improves Prediction of Dementia Beyond Alzheimer's Disease Biomarker and Mild Cognitive Impairment Diagnoses..
69:1171-1182.
2019
-
Patient Perceptions of Antihypertensive Use as a Dementia Prevention Strategy: A Mixed-Method Analysis of a Web-Based Survey..
68:523-529.
2019
-
Population-Based Approaches to Dementia Prevention..
70:S15-S17.
2019
-
Recruitment of Older Veterans with Diabetes Risk for Alzheimer's Disease for a Randomized Clinical Trial of Computerized Cognitive Training..
69:401-411.
2019
-
Regional Tau Correlates of Instrumental Activities of Daily Living and Apathy in Mild Cognitive Impairment and Alzheimer's Disease Dementia..
67:757-768.
2019
-
Retinol Binding Protein 4 Levels Are Not Altered in Preclinical Alzheimer's Disease and Not Associated with Cognitive Decline or Incident Dementia..
67:257-263.
2019
-
Systematic Multi-Domain Alzheimer's Risk Reduction Trial (SMARRT): Study Protocol..
70:S207-S220.
2019
-
Telomere Shortening in the Alzheimer's Disease Neuroimaging Initiative Cohort..
71:33-43.
2019
-
The Role of Care Navigators Working with People with Dementia and Their Caregivers..
71:45-55.
2019
-
Two Year Outcomes, Cognitive and Behavioral Markers of Decline in Healthy, Cognitively Normal Older Persons with Global Deterioration Scale Stage 2 (Subjective Cognitive Decline with Impairment)..
67:685-705.
2019
-
δ Scores Identify Subsets of "Mild Cognitive Impairment" with Variable Conversion Risks..
70:199-210.
2019
-
18F-Flortaucipir Binding in Choroid Plexus: Related to Race and Hippocampus Signal..
62:1691-1702.
2018
-
A Clinically-Translatable Machine Learning Algorithm for the Prediction of Alzheimer's Disease Conversion in Individuals with Mild and Premild Cognitive Impairment..
61:1555-1573.
2018
-
A Three-Factor Structure of Cognitive Functioning Among Unimpaired Carriers and Non-Carriers of Autosomal-Dominant Alzheimer's Disease..
65:107-115.
2018
-
Assessing Working Memory in Mild Cognitive Impairment with Serial Order Recall..
61:917-928.
2018
-
Cerebrospinal Fluid and Plasma Levels of Inflammation Differentially Relate to CNS Markers of Alzheimer's Disease Pathology and Neuronal Damage..
62:385-397.
2018
-
Clinical Evaluation of Amyloid-Related Imaging Abnormalities in Bapineuzumab Phase III Studies..
66:1409-1424.
2018
-
Clinical Experience with Cerebrospinal Fluid Aβ42, Total and Phosphorylated Tau in the Evaluation of 1,016 Individuals for Suspected Dementia..
65:1417-1425.
2018
-
Cognitive Variability Predicts Incident Alzheimer's Disease and Mild Cognitive Impairment Comparable to a Cerebrospinal Fluid Biomarker..
61:79-89.
2018
-
Comparison between FCSRT and LASSI-L to Detect Early Stage Alzheimer's Disease..
61:103-111.
2018
-
Correlates of Subjective Cognitive Decline in Lesbian, Gay, Bisexual, and Transgender Older Adults..
64:91-102.
2018
-
DNA Hypomethylation in Blood Links B3GALT4 and ZADH2 to Alzheimer's Disease..
66:927-934.
2018
-
Deep Brain Stimulation Targeting the Fornix for Mild Alzheimer Dementia (the ADvance Trial): A Two Year Follow-up Including Results of Delayed Activation..
64:597-606.
2018
-
Default Mode Network Lateralization and Memory in Healthy Aging and Alzheimer's Disease..
66:1223-1234.
2018
-
Delirium Severity Post-Surgery and its Relationship with Long-Term Cognitive Decline in a Cohort of Patients without Dementia..
61:347-358.
2018
-
Dual-Task Gait and Alzheimer's Disease Genetic Risk in Cognitively Normal Adults: A Pilot Study..
64:1137-1148.
2018
-
Exposure to Strong Anticholinergic Medications and Dementia-Related Neuropathology in a Community-Based Autopsy Cohort..
65:607-616.
2018
-
Impact of Amyloid PET Imaging in the Memory Clinic: A Systematic Review and Meta-Analysis..
64:323-335.
2018
-
Long-Term Follow Up of Patients with Mild-to-Moderate Alzheimer's Disease Treated with Bapineuzumab in a Phase III, Open-Label, Extension Study..
64:689-707.
2018
-
Memory Binding Test Predicts Incident Dementia: Results from the Einstein Aging Study..
62:293-304.
2018
-
Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease..
61:295-307.
2018
-
Patterns of Neuropsychological Dysfunction and Cortical Volume Changes in Logopenic Aphasia..
66:1015-1025.
2018
-
Plasma Antioxidant Status in Patients with Alzheimer's Disease and Cognitively Intact Elderly: A Meta-Analysis of Case-Control Studies..
62:305-317.
2018
-
Psychometric Properties of Apathy Scales in Dementia: A Systematic Review..
66:1065-1082.
2018
-
Recommendations for the Nomenclature of Cognitive Change Associated with Anaesthesia and Surgery-20181..
66:1-10.
2018
-
Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [18F]AV-1451 PET in Atypical Alzheimer's Disease..
62:1713-1724.
2018
-
Risk Factors Associated with Cortical Thickness and White Matter Hyperintensities in Dementia Free Okinawan Elderly..
63:365-372.
2018
-
Targeted Assessment of Enlargement of the Perivascular Space in Alzheimer's Disease and Vascular Dementia Subtypes Implicates Astroglial Involvement Specific to Alzheimer's Disease..
66:1587-1597.
2018
-
The Association of Mid- and Late-Life Systemic Inflammation with Brain Amyloid Deposition: The ARIC-PET Study..
66:1041-1052.
2018
-
The Effects and Meanings of Receiving a Diagnosis of Mild Cognitive Impairment or Alzheimer's Disease When One Lives Alone..
61:1517-1529.
2018
-
Trajectories of Physiological Brain Aging and Related Factors in People Aged from 20 to over-80..
65:1237-1246.
2018
-
Utility of Amyloid PET Scans in the Evaluation of Patients Presenting with Diverse Cognitive Complaints..
66:1599-1608.
2018
-
The Montreal Cognitive Assessment: Normative Data from a German-Speaking Cohort and Comparison with International Normative Samples..
64:643-655.
2018
-
A 3-Month Aerobic Training Program Improves Brain Energy Metabolism in Mild Alzheimer's Disease: Preliminary Results from a Neuroimaging Study..
56:1459-1468.
2017
-
A Novel Method for Direct Assessment of Everyday Competence Among Older Adults..
57:1229-1238.
2017
-
Alzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults..
60:1451-1459.
2017
-
Association between Cholesterol Exposure and Neuropathological Findings: The ACT Study..
59:1307-1315.
2017
-
Chronotropic Response and Cognitive Function in a Cohort at Risk for Alzheimer's Disease..
56:351-359.
2017
-
Cognitive Status, Gray Matter Atrophy, and Lower Orthostatic Blood Pressure in Older Adults..
57:1239-1250.
2017
-
Delayed Recall and Working Memory MMSE Domains Predict Delirium following Cardiac Surgery..
59:1027-1035.
2017
-
Depressive Symptoms and Tau Accumulation in the Inferior Temporal Lobe and Entorhinal Cortex in Cognitively Normal Older Adults: A Pilot Study..
59:975-985.
2017
-
Failure to Recover from Proactive Semantic Interference and Abnormal Limbic Connectivity in Asymptomatic, Middle-Aged Offspring of Patients with Late-Onset Alzheimer's Disease..
60:1183-1193.
2017
-
Interactive Effects of Dementia Severity and Comorbidities on Medicare Expenditures..
57:305-315.
2017
-
Intracranial Arterial 4D Flow in Individuals with Mild Cognitive Impairment is Associated with Cognitive Performance and Amyloid Positivity..
60:243-252.
2017
-
Memory Binding Test Predicts Incident Amnestic Mild Cognitive Impairment..
58:951-952.
2017
-
Neuropsychiatric Symptoms and Alzheimer's Disease Biomarkers Predict Driving Decline: Brief Report..
58:675-680.
2017
-
Polymorphonuclear Neutrophil Functions are Differentially Altered in Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease Patients..
60:23-42.
2017
-
Quantitative Comparison of Dense-Core Amyloid Plaque Accumulation in Amyloid-β Protein Precursor Transgenic Mice..
56:743-761.
2017
-
Recovery from Proactive Semantic Interference and MRI Volume: A Replication and Extension Study..
59:131-139.
2017
-
Recovery from Proactive Semantic Interference in Mild Cognitive Impairment and Normal Aging: Relationship to Atrophy in Brain Regions Vulnerable to Alzheimer's Disease..
56:1119-1126.
2017
-
Risk Factors and Pathological Substrates Associated with Agitation/Aggression in Alzheimer's Disease: A Preliminary Study using NACC Data..
55:1519-1528.
2017
-
The Effect of Traumatic Brain Injury History with Loss of Consciousness on Rate of Cognitive Decline Among Older Adults with Normal Cognition and Alzheimer's Disease Dementia..
59:251-263.
2017
-
The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations..
56:929-938.
2017
-
The Relationship of Brain Amyloid Load and APOE Status to Regional Cortical Thinning and Cognition in the ADNI Cohort..
59:1269-1282.
2017
-
The Role of Cerebrovascular Disease on Cognitive and Functional Status and Psychosis in Severe Alzheimer's Disease..
55:381-389.
2017
-
Validation of the Spanish Version of the LASSI-L for Diagnosing Mild Cognitive Impairment and Alzheimer's Disease..
56:733-742.
2017
-
Associations between Performance on an Abbreviated CogState Battery, Other Measures of Cognitive Function, and Biomarkers in People at Risk for Alzheimer's Disease..
54:1395-1408.
2016
-
Connected Language in Late Middle-Aged Adults at Risk for Alzheimer's Disease..
54:1539-1550.
2016
-
Developing Cognitive Markers of Alzheimer's Disease for Primary Care: Implications for Behavioral and Global Prevention..
54:1259-1272.
2016
-
Anti-Viral Properties of Amyloid-β Peptides..
54:859-878.
2016
-
A Brief Computerized Paired Associate Test for the Detection of Mild Cognitive Impairment in Community-Dwelling Older Adults..
54:793-9.
2016
-
A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer's Disease..
54:777-87.
2016
-
Changes in Neuropsychiatric Inventory Associated with Semagacestat Treatment of Alzheimer's Disease..
54:373-81.
2016
-
Lower Late-Life Body-Mass Index is Associated with Higher Cortical Amyloid Burden in Clinically Normal Elderly..
53:1097-105.
2016
-
Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition..
53:547-56.
2016
-
The Effect of Propofol Versus Isoflurane Anesthesia on Human Cerebrospinal Fluid Markers of Alzheimer's Disease: Results of a Randomized Trial..
52:1299-310.
2016
-
Dementia Risk and Protective Factors Differ in the Context of Memory Trajectory Groups..
52:1013-20.
2016
-
The Vanderbilt Memory & Aging Project: Study Design and Baseline Cohort Overview..
52:539-59.
2016
-
Blood-Borne Activity-Dependent Neuroprotective Protein (ADNP) is Correlated with Premorbid Intelligence, Clinical Stage, and Alzheimer's Disease Biomarkers..
50:249-60.
2016
-
Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future "Non-Cognitive" Outcomes of Alzheimer's Disease..
52:1055-64.
2016
-
Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease..
50:873-86.
2016
-
Evaluation of a Genetic Risk Score to Improve Risk Prediction for Alzheimer's Disease..
53:921-32.
2016
-
Future Dementia Severity is Almost Entirely Explained by the Latent Variable δ's Intercept and Slope..
49:521-9.
2016
-
Greater than the Sum of Its Parts: δ can be Constructed from Item Level Data..
49:571-9.
2016
-
Impaired Autophagy in APOE4 Astrocytes..
51:915-27.
2016
-
Less Daily Computer Use is Related to Smaller Hippocampal Volumes in Cognitively Intact Elderly..
52:713-7.
2016
-
Microbes and Alzheimer's Disease..
51:979-84.
2016
-
Mild Cognitive Impairment and Susceptibility to Scams in Old Age..
49:845-51.
2016
-
Novel Selective Calpain 1 Inhibitors as Potential Therapeutics in Alzheimer's Disease..
49:707-21.
2016
-
PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic Disease..
52:295-302.
2016
-
Protective Effect of Amyloid-β Peptides Against Herpes Simplex Virus-1 Infection in a Neuronal Cell Culture Model..
50:1227-41.
2016
-
Vitamin D and Memory Decline: Two Population-Based Prospective Studies..
50:1099-108.
2016
-
Welcome Back to Your Future: The Assessment of Dementia by the Latent Variable "δ"..
49:515-9.
2016
-
δ Scores are Exportable Across Cultural and Linguistic Boundaries..
49:561-70.
2016
-
Subjective Cognitive Decline in Older Adults: An Overview of Self-Report Measures Used Across 19 International Research Studies..
48 Suppl 1:S63-86.
2015
-
Adverse vascular risk is related to cognitive decline in older adults..
44:1361-73.
2015
-
Cognitive Effects of Soy Isoflavones in Patients with Alzheimer's Disease..
47:1009-19.
2015
-
Comprehensive gene- and pathway-based analysis of depressive symptoms in older adults..
45:1197-206.
2015
-
Depression and Suicidal Ideation During Two Psychosocial Treatments in Older Adults with Major Depression and Dementia..
48:453-62.
2015
-
Depressive Symptoms and Biomarkers of Alzheimer's Disease in Cognitively Normal Older Adults..
46:63-73.
2015
-
Ethnicity moderates dementia's biomarkers..
43:275-87.
2015
-
Inclusion of an informant yields strong associations between cognitive complaint and longitudinal cognitive outcomes in non-demented elders..
43:121-32.
2015
-
Insulin Resistance is Associated with Higher Cerebrospinal Fluid Tau Levels in Asymptomatic APOEɛ4 Carriers..
46:525-33.
2015
-
NK Cells are Activated in Amnestic Mild Cognitive Impairment but not in Mild Alzheimer's Disease Patients..
46:93-107.
2015
-
Neuropsychiatric Symptoms and Functional Connectivity in Mild Cognitive Impairment..
46:727-35.
2015
-
New Perspectives on Alzheimer's Disease and Nutrition..
46:1111-27.
2015
-
Quantitative measurement of [Na+] and [K+] in postmortem human brain tissue indicates disturbances in subjects with Alzheimer's disease and dementia with Lewy bodies..
44:851-7.
2015
-
Relationship between Systemic and Cerebral Vascular Disease and Brain Structure Integrity in Normal Elderly Individuals..
44:319-28.
2015
-
Serum leptin and risk of cognitive decline in elderly italians..
44:1231-9.
2015
-
Subjective memory complaint only relates to verbal episodic memory performance in mild cognitive impairment..
44:309-18.
2015
-
The Apathy Evaluation Scale: A Comparison of Subject, Informant, and Clinician Report in Cognitively Normal Elderly and Mild Cognitive Impairment..
47:421-32.
2015
-
Voxel Level Survival Analysis of Grey Matter Volume and Incident Mild Cognitive Impairment or Alzheimer's Disease..
46:167-78.
2015
-
Decreased Neurotrophic Support is Associated with Cognitive Decline in Non-Demented Subjects..
46:423-9.
2015
-
A new algorithm for predicting time to disease endpoints in Alzheimer's disease patients..
38:661-8.
2014
-
A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease..
38:111-20.
2014
-
Age-associated changes of brain copper, iron, and zinc in Alzheimer's disease and dementia with Lewy bodies..
42:1407-13.
2014
-
Arterial stiffness and cognitive function in the elderly..
42 Suppl 4:S503-14.
2014
-
Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates..
42:275-89.
2014
-
Regional cortical thinning and cerebrospinal biomarkers predict worsening daily functioning across the Alzheimer's disease spectrum..
41:719-28.
2014
-
Regional fluorodeoxyglucose metabolism and instrumental activities of daily living across the Alzheimer's disease spectrum..
42:291-300.
2014
-
The KEEPS-Cognitive and Affective Study: baseline associations between vascular risk factors and cognition..
40:331-41.
2014
-
Cortical and subcortical cerebrovascular resistance index in mild cognitive impairment and Alzheimer's disease..
36:689-98.
2013
-
Coupled cognitive and functional change in Alzheimer's disease and the influence of depressive symptoms..
34:851-60.
2013
-
Interaction of age and APOE genotype on cerebral blood flow at rest..
34:921-35.
2013
-
Lessons from epidemiologic research about risk factors, modifiers, and progression of late onset Alzheimer's Disease in New York City at Columbia University Medical Center..
33 Suppl 1:S447-55.
2013
-
5-HT₄ receptor stimulation leads to soluble AβPPα production through MMP-9 upregulation..
32:437-45.
2012
-
Amyloid-β(1-15/16) as a marker for γ-secretase inhibition in Alzheimer's disease..
31:335-41.
2012
-
Functional MRI of mnemonic networks across the spectrum of normal aging, mild cognitive impairment, and Alzheimer's disease..
31 Suppl 3:S155-67.
2012
-
Markers of cholesterol metabolism in the brain show stronger associations with cerebrovascular disease than Alzheimer's disease..
30:53-61.
2012
-
The effects of ramipril in individuals at risk for Alzheimer's disease: results of a pilot clinical trial..
32:147-56.
2012
-
Association of HSP70 and its co-chaperones with Alzheimer's disease..
25:93-102.
2011
-
Gender differences in tea, coffee, and cognitive decline in the elderly: the Cardiovascular Health Study..
27:553-66.
2011
-
Independent component analysis-based classification of Alzheimer's disease MRI data..
24:775-83.
2011
-
Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer's disease: results of a randomized controlled trial..
26:495-505.
2011
-
Can statins prevent or help treat Alzheimer's disease?.
20:925-33.
2010
-
Circulating angiogenic cells and Alzheimer's disease: contribution of the bone marrow to the pathogenesis of the disease..
19:1241-3.
2010
-
Comparison of conventional ELISA with electrochemiluminescence technology for detection of amyloid-β in plasma..
21:769-73.
2010
-
Mediterranean diet, inflammatory and metabolic biomarkers, and risk of Alzheimer's disease..
22:483-92.
2010
-
Validating predicted biological effects of Alzheimer's disease associated SNPs using CSF biomarker levels..
21:833-42.
2010
-
Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease..
22:1305-11.
2010
-
Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice..
17:681-97.
2009
-
Effects of memantine on cerebrospinal fluid biomarkers of neurofibrillary pathology..
18:509-13.
2009
-
The accuracy of Medicare claims as an epidemiological tool: the case of dementia revisited..
17:807-15.
2009
-
Increased neurogenesis in young transgenic mice overexpressing human APP(Sw, Ind)..
12:229-40.
2007
-
The search for antecedent biomarkers of Alzheimer's disease..
8:347-58.
2005
-
Anti-CMV IgG Seropositivity is Associated with Plasma Biomarker Evidence of Amyloid-β Accumulation
2024
-
Tryptophan Metabolism and Neurodegeneration: Longitudinal Associations of Kynurenine Pathway Metabolites with Cognitive Performance and Plasma Alzheimer's Disease and Related Dementias Biomarkers in the Duke Physical Performance Across the LifeSpan Study
2023
-
Tryptophan Metabolism and Neurodegeneration: Longitudinal Associations of Kynurenine Pathway Metabolites with Cognitive Performance and Plasma Alzheimer’s Disease and Related Dementias Biomarkers in the Duke Physical Performance Across the LifeSpan Study
2022
-
The Montreal Cognitive Assessment: Normative Data from a German-Speaking Cohort and Comparison with International Normative Samples
2018
-
The Montreal Cognitive Assessment: Normative Data from a German-Speaking Cohort and Comparison with International Normative Samples
2018
-
The Montreal Cognitive Assessment: Normative Data from a German-Speaking Cohort and Comparison with International Normative Samples
2018
-
The Montreal Cognitive Assessment: Normative Data from a German-Speaking Cohort and Comparison with International Normative Samples
2018
-
The Montreal Cognitive Assessment: Normative Data from a German-Speaking Cohort and Comparison with International Normative Samples
2018
Identity
International Standard Serial Number (ISSN)
-
1387-2877
-
1875-8908
-
18758908 13872877